Infinion Biopharma Limited, a active public limited company, was established on 16 January 2018 in Ahmedabad, Gujarat, India. Engaging in biotechnology within the manufacturing sector, it holds CIN: U51909GJ2018PLC100571. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹17.50 Cr and a paid-up capital of ₹10.59 Cr.
Formerly known as Infinion Biopharma Private Limited, Glia Biopharmaceutical Private Limited. Its leadership includes Pankaj Kumar Singh (Director), Gautam Bali (Director), Vishal Harshvardhan Jain (Director). Past directors included Pankaj Kumar Singh, Ram Kishankumar Shah, Niraliben Lalitbhai Solanki. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 407, Silver Radiance, Pakwan Char Rasta, Sindhu Bhavan Road, B, Odakdev, Ahmedabad, Gujarat, 380054.
U51909GJ2018PLC100571
100571
16 January 2018
₹17.50 Cr
₹10.59 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Infinion Biopharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pankaj Kumar Singh | Director | 30 Sep 2019 | Current |
| Gautam Bali | Director | 25 Jul 2018 | Current |
| Vishal Harshvardhan Jain | Director | 10 Mar 2018 | Current |
| Dhruv Desai | Managing Director | 07 Sep 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Jun 2021 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Director | 26 Jul 2022 | Past |
| Pramod Abcsdd | Cfo(Kmp) | - | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Director | 27 Nov 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Infinion Biopharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1068.79% increase. The company also saw a substantial improvement in profitability, with a 3927.62% increase in profit. The company's net worth Soared by an impressive increase of 33.6%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Infinion Biopharma had a promoter holding of 76.22% and a public holding of 23.77%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Infinion Biopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Infinion Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Infinion Biopharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Dhruv Desai was appointed as a Managing Director was appointed as a Managing Director on 07 Sep 2025 & has been associated with this company since 3 months 17 days . was documented.
Infinion Biopharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Shivani Pathak was appointed as a Company Secretary was appointed as a Company Secretary on 09 Sep 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.
Infinion Biopharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
Progress on Pankaj Kumar Singh was appointed as a Director was appointed as a Director on 30 Sep 2019 & has been associated with this company since 6 years 2 months . was documented.
Gautam Bali was appointed as a Director was appointed as a Director on 25 Jul 2018 & has been associated with this company since 7 years 5 months . was recorded as a recent event.
The CIN of Infinion Biopharma Limited is U51909GJ2018PLC100571.
Infinion Biopharma Limited is headquartered at 407, Silver Radiance, Pakwan Char Rasta, Sindhu Bhavan Road, B, Odakdev, Ahmedabad, Gujarat, 380054.
Infinion Biopharma Limited was incorporated on 16 January 2018.
The current directors of Infinion Biopharma Limited are
The primary industry of Infinion Biopharma Limited is Manufacturing.
Infinion Biopharma Limited is unlisted.
The authorized capital of Infinion Biopharma Limited is ₹17.50 Cr, and the paid-up capital is ₹10.59 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX